ENTPD1 and acute myeloid leukemia: Thus, CD39-P2RY13-cAMP-OxPHOS axis plays a key role in cytarabine resistance; inhibiting CD39 ecto-ATPase activity enhanced cytarabine’s cytotoxicity in AML by blocking the mitochondrial reprogramming caused by the drug[36].